Alexandria Pharmaceuticals
AXPH
AXPH
Adjusted financial results of Alexandria Pharmaceuticals & Chemical Industries for FY12/13 showed EGP47.879 million net profit, compared with EGP 44.358 million a year earlier.
The results were adjusted as per decisions of the ordinary general meeting dated October 6, 2013.
The results were adjusted as per decisions of the ordinary general meeting dated October 6, 2013.
Source:
Mubasher
